Blood Transfusion by Boston MedFlight Registry

Status Recruiting

Clinical Trial Summary

The primary aim of this observational registry is to study the outcomes of patients with hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.

Clinical Trial Description

Boston MedFlight, a critical care transport organization, based on a consortium of the academic medical centers in Boston, will begin carrying PRBC in 2019. The program is intended to provide BMF clinicians with 24-hour immediate access to appropriate blood products to be utilized if needed for patients following life-threatening illness or injury. The four fundamental goals of this program are: save lives' ensure transfusion safety; minimize blood product waste; and conduct continuous quality assurance. Our goal is to observationally evaluate this new protocol of administering blood products in the pre-hospital setting. We will collect data on patients with hemorrhagic shock being transported by Boston MedFlight, who receive or would have been eligible to receive pre-hospital blood transfusion by the inclusion criteria. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04610814
Study type	Observational [Patient Registry]
Source	Massachusetts General Hospital
Contact	Angela Renne
Phone	617-643-2440
Email	ARENNE@MGH.HARVARD.EDU
Status	Recruiting
Phase
Start date	November 1, 2019
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04149171` - Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage	Phase 3
Not yet recruiting	`NCT06070350` - Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children	Phase 3
Not yet recruiting	`NCT02880163` - REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam	N/A
Completed	`NCT02924792` - Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis	N/A
Terminated	`NCT00750997` - Hypertonic Modulation of Inflammation Following Injury	N/A
Terminated	`NCT03477006` - Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial	Phase 3
Not yet recruiting	`NCT04987411` - Detection of Exhaled Methane Levels in Hemorrhagic Shock
Completed	`NCT02071290` - Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock	N/A
Completed	`NCT03535441` - HMGB1 Release From Hemorrhagic Shock Patients
Completed	`NCT03480555` - Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients	N/A
Completed	`NCT03402035` - Shock, Whole Blood, and Assessment of TBI S.W.A.T. (LITES TO 2)
Completed	`NCT05081063` - Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients	Phase 3
Recruiting	`NCT03235921` - Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock	Phase 2
Active, not recruiting	`NCT03469947` - California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA	Phase 3
Completed	`NCT01411852` - Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma	Phase 2
Withdrawn	`NCT01221389` - Study Using Plasma for Patients Requiring Emergency Surgery	Phase 4
Recruiting	`NCT03406598` - Bedside Visual Analysis of Sublingual Microcirculation in Shock Patients
Completed	`NCT00328133` - The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry	N/A
Completed	`NCT00379522` - Vasopressin in Traumatic Hemorrhagic Shock Study	Phase 2/Phase 3
Completed	`NCT00945542` - The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study)	Phase 1/Phase 2